Searchable abstracts of presentations at key conferences in endocrinology

ea0022oc6.6 | Bone | ECE2010

Suppression of circulating fibroblast growth factor-23 by cinacalcet in patients with primary hyperparathyroidism

Imanishi Yasuo , Kurajoh Masafumi , Kobayashi Keisuke , Ishii Akira , Nagata Tomoki , Miki Takami , Inaba Masaaki , Nishizawa Yoshiki

While the importance of fibroblast growth factor 23 (FGF-23) is established in the pathogenesis of phosphate wasting disorders, little is known about the mechanisms regulating its circulating level. To investigate the role of parathyroid hormone (PTH) in FGF-23 homeostasis, cinacalcet hydrochloride, a calcimimetic compound to suppress PTH secretion, was administered to the patients with primary hyperparathyroidism (PHPT). Fourteen patients with PHPT, who met the guidelines of ...